Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms

Transplantation

Volumn 87, Issue 12, 2009, Pages 1801-1806

  Girnita, Diana M ^a   Webber, Steven A ^a   Brooks, Maria M ^b   Ferrell, Robert ^c   Girnita, Alin L ^a   Burckart, Gilbert J ^d   Chinnock, Richard ^e   Canter, Charles ^f   Addonizio, Linda ^g   Bernstein, Daniel ^h   Kirklin, James K ⁱ   Naftel, David ⁱ   Zeevi, Adriana ^a,j  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e LOMA LINDA UNIVERSITY   (United States)

^f ST LOUIS CHILDREN S HOSPITAL   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ Kentucky   (United States)

^j NONE   (United States)

more..

Author keywords

Gene polymorphism; Granzyme B; Heart; Pediatric; Transplantation

Indexed keywords

GRANZYME B;

ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRANZYME B GENE; HEART TRANSPLANTATION; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MORPHOLOGICAL TRAIT; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CONTINENTAL POPULATION GROUPS; DNA PRIMERS; ETHNIC GROUPS; GENETIC VARIATION; GENOTYPE; GRAFT REJECTION; GRANZYMES; HEART TRANSPLANTATION; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 67649588842     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a755a4     Document Type: Article

References (26)

1. Dugre FJ, Gaudreau S, Belles-Isles M, et al. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation 2000; 70: 1074.
2. Pascoe MD, Marshall SE, Welsh KI, et al. Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B, and Fas ligand fine-needle aspiration immunocytology. Transplantation 2000; 69: 2547.
3. Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562.
4. Cle'ment MV, Soulie' A, Legros-Maida S, et al. Perforin and granzyme B: Predictive markers for acute GVHD or cardiac rejection after bone marrow or heart transplantation. Nouv Rev Fr Hematol 1991; 33: 465.
5. Bittmann I, Muller C, Behr J, et al. Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-A human biopsy study. Virchows Arch 2004; 445: 375.
6. Zeevi A, Pavlakis M, Spichty K, et al. Prediction of rejection in lung transplantation. Transplant Proc 2001; 33: 291.
7. Cashion A, Sabek O, Driscoll C, et al. Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant. Clin Transplant 2006; 20: 106.
8. Corti B, Altimari A, Gabusi E, et al. Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients. Transplant Proc 2005; 37: 4467.
9. D'Errico A, Corti B, Pinna AD, et al. Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation. Transplant Proc 2003; 35: 3061.
10. Takahashi A, Horie O, Murayama T, et al. [Levels of granzyme B, perforin and Fas ligand antigens and mRNAs in patients following allogeneic hematopoietic stem cell transplantation]. Rinsho Byori 2003; 51: 1167.
11. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323.
12. McIlroy D, Cartron PF, Tuffery P, et al. A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci USA 2003; 100: 2562.
13. Sun J, Bird CH, Thia KY, et al. Granzyme B encoded by the commonly occurring humanRAHallele retains pro-apoptotic activity. J Biol Chem 2004; 279: 16907.
14. Shafer-Weaver K, Sayers T, Strobl S, et al. The Granzyme B ELISPOT assay: An alternative to the 51Cr-release assay for monitoring cellmediated cytotoxicity. J Transl Med 2003; 1: 14.
15. Gerrits JH, van de Wetering J, Ijzermans JN, et al. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation. Transplant Proc 2005; 37: 752.
16. Malyguine A, Strobl S, Zaritskaya L, et al. New approaches for monitoring CTL activity in clinical trials. Adv Exp Med Biol 2007; 601: 273.
17. Zaitsu M, Yamamoto K, Ishii E, et al. High frequency of QPY allele and linkage disequilibrium of granzyme-B in Epstein-Barr-virusassociated hemophagocytic lymphohistiocytosis. Tissue Antigens 2004; 64: 611.
18. Janetzki S, Cox JH, Oden N, et al. Standardization and validation issues of the ELISPOT assay. Methods Mol Biol 2005; 302: 51.
19. Karlsson AC, Martin JN, Younger SR, et al. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods 2003; 283: 141.
20. Nowacki TM, Kuerten S, Zhang W, et al. Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells. Cell Immunol 2007; 247: 36.
21. Densem CG, Hutchinson IV, Yonan N, et al. Donor and recipienttransforming growth factor-beta 1 polymorphism and cardiac transplantrelated coronary artery disease. Transpl Immunol 2004; 13: 211.
22. Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: Can our genes predict clinical outcome? Expert Rev Mol Med 2007; 9: 1.
23. Gunesacar R, Opelz G, Erken E, et al. VEGF 936 C/T gene polymorphism in renal transplant recipients: Association of the T allele with good graft outcome. Hum Immunol 2007; 68: 599.
24. Girnita DM, Brooks MM, Webber SA, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study. Transplantation 2008; 85: 1632.
25. Girnita DM, Webber SA, Zeevi A. Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation. Clin Lab Med 2008; 28: 423.
26. Girnita DM, Webber SA, Ferrell R, et al. Disparate distribution of 16 candidate single nucleotide polymorphismsamongracialandethnic groups of pediatric heart transplant patients. Transplantation 2006; 82: 1774.